Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 August 2007, Vol. 110, No. 3, pp. 928-936.
Prepublished online as a Blood First Edition Paper on April 17, 2007; DOI 10.1182/blood-2007-01-069112.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2007-01-069112v1
110/3/928    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petrovas, C.
Right arrow Articles by Koup, R. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petrovas, C.
Right arrow Articles by Koup, R. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted January 22, 2007
Accepted April 10, 2007

SIV-specific CD8+T-cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection

Constantinos Petrovas*, David A Price, Joseph Mattapallil, David R Ambrozak, Christof Geldmacher, Valentina Cecchinato, Monica Vaccari, Elzbieta Tryniszewska, Emma Gostick, Mario Roederer, Daniel C Douek, Sara H Morgan, Simon J Davis, Genoveffa Franchini, and Richard A Koup

Immunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, MD, United States
Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, United States
ImmunoTechnology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, United States
Animal Models and Retroviral Vaccines Section, National Cancer Institute, NIH, Bethesda, MD, United States
Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

* Corresponding author; email: petrovasc{at}mail.nih.gov.

Programmed Death-1 (PD-1) is a critical mediator of virus-specific CD8+ T cell exhaustion. Here, we examined the expression of PD-1 on SIV-specific CD8+ T cells and its possible involvement in regulation of cytokine production, proliferation and survival of these cells. The majority of SIV-specific CD8+ T cells expressed a PD-1high phenotype, independent of their differentiation status, in all tissues tested. PD-1 expression gradually declined on CD8+ T cells specific for SIV-derived epitopes that had undergone mutational escape, indicating that antigen-specific TCR stimulation is the primary determinant of PD-1 expression. SIV-specific PD-1high CD8+ T cells produced IFN-{gamma}, TNF-{alpha} and IL-2 under cognate peptide stimulation. While CD8+ T cells that proliferated in response to antigen had a PD-1high phenotype, it was determined that there was a reduced proliferative capacity of PD-1high compared to PD-1low SIV-specific CD8+ T cells. PD-1high SIV-specific CD8+ T cells were highly susceptible to cell death leading to loss of such cells after in vitro stimulation. Thus, PD-1 is a negative regulator of SIV-specific CD8+ T cells, operating predominantly through the induction of cell death. Manipulation of the interaction of PD-1 with its ligands could thus potentially restore the CD8+ T cell responses in SIV infection.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Petrovas, B. Chaon, D. R. Ambrozak, D. A. Price, J. J. Melenhorst, B. J. Hill, C. Geldmacher, J. P. Casazza, P. K. Chattopadhyay, M. Roederer, et al.
Differential Association of Programmed Death-1 and CD57 with Ex Vivo Survival of CD8+ T Cells in HIV Infection
J. Immunol., July 15, 2009; 183(2): 1120 - 1132.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Bucks, J. A. Norton, A. C. Boesteanu, Y. M. Mueller, and P. D. Katsikis
Chronic Antigen Stimulation Alone Is Sufficient to Drive CD8+ T Cell Exhaustion
J. Immunol., June 1, 2009; 182(11): 6697 - 6708.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. E. Kaufmann and B. D. Walker
PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention
J. Immunol., May 15, 2009; 182(10): 5891 - 5897.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. N. Blattman, E. J. Wherry, S.-J. Ha, R. G. van der Most, and R. Ahmed
Impact of Epitope Escape on PD-1 Expression and CD8 T-Cell Exhaustion during Chronic Infection
J. Virol., May 1, 2009; 83(9): 4386 - 4394.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Rutebemberwa, S. C. Ray, J. Astemborski, J. Levine, L. Liu, K. A. Dowd, S. Clute, C. Wang, A. Korman, A. Sette, et al.
High-Programmed Death-1 Levels on Hepatitis C Virus-Specific T Cells during Acute Infection Are Associated with Viral Persistence and Require Preservation of Cognate Antigen during Chronic Infection
J. Immunol., December 15, 2008; 181(12): 8215 - 8225.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. C. Zahn, M. D. Rett, B. Korioth-Schmitz, Y. Sun, A. P. Buzby, S. Goldstein, C. R. Brown, R. A. Byrum, G. J. Freeman, N. L. Letvin, et al.
Simian Immunodeficiency Virus (SIV)-Specific CD8+ T-Cell Responses in Vervet African Green Monkeys Chronically Infected with SIVagm
J. Virol., December 1, 2008; 82(23): 11577 - 11588.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. B. Jones, L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al.
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
J. Exp. Med., November 24, 2008; 205(12): 2763 - 2779.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. A. Hafler and V. Kuchroo
TIMs: central regulators of immune responses
J. Exp. Med., November 24, 2008; 205(12): 2699 - 2701.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. D. Blackburn, H. Shin, G. J. Freeman, and E. J. Wherry
Selective expansion of a subset of exhausted CD8 T cells by {alpha}PD-L1 blockade
PNAS, September 30, 2008; 105(39): 15016 - 15021.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Estes, S. N. Gordon, M. Zeng, A. M. Chahroudi, R. M. Dunham, S. I. Staprans, C. S. Reilly, G. Silvestri, and A. T. Haase
Early Resolution of Acute Immune Activation and Induction of PD-1 in SIV-Infected Sooty Mangabeys Distinguishes Nonpathogenic from Pathogenic Infection in Rhesus Macaques
J. Immunol., May 15, 2008; 180(10): 6798 - 6807.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S.-J. Ha, S. N. Mueller, E. J. Wherry, D. L. Barber, R. D. Aubert, A. H. Sharpe, G. J. Freeman, and R. Ahmed
Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection
J. Exp. Med., March 17, 2008; 205(3): 543 - 555.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020